U
Ulf Müller-Ladner
Researcher at University of Giessen
Publications - 644
Citations - 32784
Ulf Müller-Ladner is an academic researcher from University of Giessen. The author has contributed to research in topics: Medicine & Arthritis. The author has an hindex of 77, co-authored 590 publications receiving 27658 citations. Previous affiliations of Ulf Müller-Ladner include University of Regensburg & University of Genoa.
Papers
More filters
Journal ArticleDOI
FRI0143 A randomized, double-blind, phase 3 study demonstrates clinical equivalence of CT-P13 to infliximab when co-administered with methotrexate in patients with active rheumatoid arthritis
Dae-Hyun Yoo,Pedro Miranda,Mariusz Piotrowski,Edgar Ramiterre,Volodymyr Kovalenko,Nenad Prodanovic,Michael L. Tee,Sergio Gutierrez-Ureña,Renato Jimenez,Omid Zamani,Sang Joon Lee,HoUng Kim,Won Park,Ulf Müller-Ladner +13 more
TL;DR: CT-P13 was well tolerated, with an efficacy and safety profile comparable to that of infliximab up to week 30, and are equivalent in terms of ACR20 in patients with RA.
Journal ArticleDOI
OP0036 An Evidence-Based Tool for Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis: The Detect Study
Christopher P. Denton,JG Coghlan,Ekkehard Grünig,Diana Bonderman,Oliver Distler,Dinesh Khanna,Ulf Müller-Ladner,Janet E. Pope,Madelon C. Vonk,Martin Doelberg,Harbajan Chadha-Boreham,Harald Heinzl,Daniel M Rosenberg,Vallerie V. McLaughlin,James R. Seibold +14 more
TL;DR: The two-step DETECT algorithm is a sensitive, non-invasive tool to facilitate early detection of PAH in SSc patients with a low DLCO, addressing resource utilisation of echocardiography and RHC and, most importantly, minimising missed diagnoses.
Journal ArticleDOI
[Evolution of biologicals in inflammation medicine--biosimilars in gastroenterology, rheumatology and dermatology].
Stefan Schreiber,T. Luger,Thomas Mittendorf,Ulrich Mrowietz,Ulf Müller-Ladner,J. Schröder,Andreas Stallmach,B Bokemeyer +7 more
TL;DR: After expiration of the national patent protection in beginning of 2015, the infliximab biosimilars will be launched on the market in Germany and will be part of the therapeutic arsenal in gastroenterology, rheumatology and dermatology.
Journal ArticleDOI
Vasculitis of the aortic arch and cardiac valves as the cause of relapsing fever of unknown origin in an elderly, white man
Florian Obermeier,T. Herold,Johann Schönberger,Ingo H. Tarner,Christoph Eilles,J. Schölmerich,Thomas Glück,Frank Kullmann,Ulf Müller-Ladner +8 more
TL;DR: A 2-[18F]-fluoro-2-deoxy-d-glucose-positron emission tomography was performed, revealing a markedly enhanced glucose uptake in the ascending aorta and the cardiac valves, indicating vasculitis as the cause of FUO in this patient.
Journal ArticleDOI
Evidenzbasierte Therapie des Raynaud-Syndroms
M Distler,J. H. W. Distler,Adrian Ciurea,Diego Kyburz,Ulf Müller-Ladner,Kristian Reich,Oliver Distler +6 more
TL;DR: As analyzed by meta-analyses, nifedipine showed improvement of the peripheral circulation, as well as reduction of both the intensity and frequency of attacks in patients with primary and secondary Raynaud’s syndrome as compared to placebo.